Event-Driven Stocks

PETRO USA, INC.

Healthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕

Signs● 3 good● 1 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY23FY22FY21FY20FY19FY18
Revenue——————
Operating income−$23,581−$12,860−$27,992−$17,335−$13,719−$33,292
Net income−$23,863−$13,143−$28,004−$17,335−$13,719−$33,292
Total assets$100$0$0$0$0$0
Total liabilities$128,506$104,543$111,400$90,896$73,561$59,842
Equity−$128,406−$104,543−$111,400−$90,896−$73,561−$59,842
EPS (diluted)——$-0.91———
Shares out.30,920200.0M30,9202.96B2.96B2.96B

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2023
Operating margin
—
Net margin
—
Return on equity
18.6%
Return on assets
−23863.0%
Return on capital (ROCE)
—
Liabilities / assets
128506.0%
Debt / equity
—
Book value / share
$-4.15
Revenue growth (YoY)
—
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2023
Altman Z″ (distress)
-3981522.22distress
Accruals / assets
−23963.0%clean
Piotroski F-Score
3/4weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
46
/ 100
Profitability 50Growth n/aCatalyst 33Earnings quality 100Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 3 severe● 1 warning● 3 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • High leverage (liabilities > 70% of assets)
  • Strong return on equity (>15%)
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Insider transactions

SEC Form 4 · most recent
0 acquisitions1 disposalsnet −2.50B shares · last 1
InsiderDateTypeSharesPrice
Gates E RobertOfficer — Chairman and CEOSep 20, 2010U2.50B$0.00

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)